Indians trust doctors more than chemists

New Delhi: "We can crib payment of doctors, but always returning to them for minor illnesses. Global survey conducted among 27,000 internet users in 54 countries found that U.S. company Nielsen increasingly rely on doctors, pharmacists that (Chemistry).

During interviews, usually they are dealing with 17 common minor ailments such as cough and cold, headaches, which can be treated without prescription medicines. Many said they prefer the U.S. to seek the advice of a doctor that rely on the opinion of the neighborhood pharmacist. But they will do it only when symptoms are severe.

"Consumer response to their review to consult with your doctor or pharmacist varied depending on the disease, but it created a: for every disease the U.S. will consult a doctor for their neighborhood pharmacist," said City Seturaman, Director (Client Solution), Nielsen.

Most U.S. doctors seek advice for hay fever, 33%, followed by sinus congestion, 23%, and influenza, 21%. They rarely consider visiting doctor menstrual pain, 54%, Hangover, 47%, and problems with sleep, 34%. But such problems, they say, ask or pharmacist.

The survey said the U.S. does not see as a beginning point of care pharmacists are perceived as a retail product, not the consultants for the treatment of lung nezduzhan.

One study says Americans, the U.S. is likely to see a doctor, but Europeans will visit the pharmacist. In case of headaches, such as

Americans almost always possible to make a quick trip to a pharmacy for aspirin or ibuprofen, and Europeans are likely to visit pharmacies to talk to the pharmacist for advice.

"This discovery shows that most consumers (especially European), suffering from minor ailments, ready to work due to illness without professional advice, or non-means or other traditional means of protection, giving the body or self -correction, "said Robert Buckeldee, model Service Director, Nielsen.

Indian pharmaceutical patents in the case of a surge increase in U.S. expiries

Mumbai: In the period between 2010 and 2015, drugs mindboggling $ 157 billion should go to a patent in the U.S., according to industry analysts.
In contrast, in India in 2015 - just when the Indian pharmaceutical market, will cost $ 20 billion - about 15% of drugs that are patented molecules.

70000 Patent applications are in the process and knowledge in this country, "said PH Kurian, Secretary of the controller patents, trademarks and industrial designs.

"From 2005 to date, nearly 13,000 patents were issued in both chemicals and pharmaceuticals," he said.

Accelerated growth in patenting in India in connection with the introduction of patents and a 20-year patent term in 2005, after India signed the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO) in 1995.

"At that moment there was an adventure, chips went up, and in the future they will continue to grow. In the U.S., although expiries and looks into her eyes, saw dust," said Anuradha Salhotra, managing partner at intellectual property law firm Lall, Lahiri & Salhotra.

At a time when the increasing costs of health care create obstacles to governments around the world, whether India can afford the patented drug questions begging answers.

According to the consulting firm Health Department Technopak, provides the average share of household spending on health is expected to increase from 7% to 13% over the next two decades.

According to K. Keayla, organizer of the National Working Group on Patent Law, patent monopoly money without having to lower prices for generic drugs for exhalation. "The public will suffer as a monopoly of the patent holder to set high prices.

JK CAD, chairman, founder and CEO of the Association of Cancer Care, said that if drastic steps made in making medicines, will be the stage when 90-95% of the population in India will not accept relief funds on account of high prices.

How many people can afford to pay more than 400000 rupees for 24-week training course for Hepatitis C can be patented, said Eldred Tellis, director of Sankalp rehabilitation Trust, Mumbai NGOs working with hepatitis C and AIDS.

"There is a patented medicine for breast cancer price of Rs16 Laja-18 for treatment each year, which seems out of reach of a great nation," says CAD.

Companies have been filing for patents represent various forms of the same drugs, including salt, polymorphic form, analog form, crystalline forms, solid dosage forms, combining the drug with other drugs, etc. (DNA Money, March 5, 2010).

Amit Sengupta, General Secretary of All India Peoples Science Network, said that the number of applications to improve the work of patent offices, and may not be likely to get wrong.

Lilly warns patients, doctors on the stolen drugs

SAN FRANCISCO (Reuters) - Eli Lilly & Co. / quotes/comstock/13 *! Lly / quotes / nls / lly (LLY 36.22, 0.04, 0.11%) reported Wednesday that consumers should be wary of drugs that were recently stolen from a warehouse in Enfield, Conn. Apparently, about 75 million dollars in anti-depressants and anti-psychotic drugs and others were stolen from the distribution point in a burglary cleverly staged on Sunday. Lilly, if the marks were stolen Alimta, Cymbalta, Effient, Gemzar, Prozac, Strattera, Symbyax and Zyprexa. "Consumers should buy only Lilly's well-established retailers and good reputation", the pharmaceutical group said in a statement. "Lilly recommends that consumers always check the label for products and signs of deterioration before the opening. "

75 million dollars of antipsychotics - That's a lot of pills, and I am not surprised that the thieves used a tractor-trailer to transport everything off. You would have to assume that there is a well-worked-out way to unload all these things, and nobody will go to all this trouble on "spec".

Glad to see that the products of my industry are in such demand. . .

Both companies make in the field of pharmacy and the transaction is expected to be the biggest biotech deal signed by an Australian company. Experts say the total contract value is 600 million which includes royalties.

It boils down to a value of $ 3.75 per share Acrux. This expert opinion is worth the gamble.

Meanwhile, the journal of the drug remains to be done by the Food and Drug Administration (FDA). Only after a green signal to the authority of the United States is given that the drug will be sold in the United States and many other international markets.